BIT Mesra Bioengineering/Biotech JRF Vacancy


Advertisement for Requirement of Junior Research Fellow 

Applications are invited for the post of Junior Research Fellow in following project funded under SERB-CRG (2022-2025) 

1. Development of Novel Antileukemics Through the Structural and Functional Studies of Engineered and Chimeric Plant-Type Asparaginases File No.: CRG//2021/006543 

Dr. K K Pradhan, Dr. V K Nigam & Dr. H R Singh 

Junior Research Fellow 

Eligibility: M. Tech./M.S/M. Pharm./M.Sc. in Bioengineering/ Biotechnology/ Pharm. Biotechnology. NET/GATE/GPAT or other national level examination qualifiers will be preferred. 

Desirable skills: Design of Protein expression & purification, Local engineering (circular permutation, linker modification, motifs exchange, randomization), QbD, chimera-genesis and Exposure in SDSPAGE as well as XRD techniques. Initially for a period of 01 year & may be extended for a additional 02 year upon satisfactory performance 

31,000/- + HRA as applicable (First 2 Years) 35,000/- + HRA as applicable (Third Year) 

Date and time of Interview: 26 th April 2022 & at 9.15 AM 

Venue: Department of Pharmaceutical Sciences & Technology, BIT-Mesra 


 Interested candidates are required to bring all original Certificates and testimonials along with one set of duly attested photocopy on the interview date. No TA/DA will be provided for attending the Interview. 
 Candidates may please forward their Bio-data in advance to Dr. Kishanta Kumar Pradhan (Principal Investigator of the Project) through e-mail (kkpradhan@bitmesra.ac.in) within 20.04.2022. 
 Candidates appearing for online/offline interview should covey in advance to the PI. 
 Selected candidate are expected to enroll for Ph.D. program of the institute after fulfilling admission criteria and would be given preference. 

Terms & Conditions: 

1. No TA/DA will be paid for attending the interview. 
2. The above position is purely contractual. 
3. Canvassing in any form will disqualify the candidate.

More Info: 

Post a Comment

0 Comments